Discover how Verve Therapeutics’ new patent for gene editing targeting the PCSK9 gene could revolutionize LDL cholesterol treatment and combat cardiovascular disease.
No Increase in Major Cardiac Events With Testosterone-Replacement Therapy
CHICAGO — Testosterone-replacement therapy was noninferior to placebo in the occurrence of major adverse cardiac events among men with hypogonadism and established or high risk
June 17, 2023